MPX Bioceutical Corporation is a multinational diversified cannabis company focused on the medical and adult use cannabis markets.
The company has a growing presence in the U.S. with imminent plans for ten dispensaries and four production facilities in four states. It also has a production facility under construction in Canada as well as a pending licence application to Health Canada.
In addition to its well established Melting Point Extracts (MPX) brand, the company’s foundation is built on its profitable operations in Arizona, where it has two fully operational Health for Life dispensaries and a third slated to open in Q2/2018. MPX also recently acquired The Holistic Center, giving it a total of four dispensaries in this state.
In Nevada, MPX is operating GreenMart, a fully licensed cultivation, production and wholesale cannabis business.
In Massachusetts, the construction of the first of three dispensaries is underway as is construction of a cultivation and processing facility in Falls Rivers.
MPX is also managing three dispensaries and one production facility in Maryland (which are not yet operational) and has options to acquire each facility.
On August 23, 2017, the Company was advised that its application for Licensed Producer status from Health Canada was at the Detailed Review and Initiation of Security Clearance Process stage and has started construction of its 72,342 square foot production facility.
With all production facilities, MPX anticipates that it will have 9 million grams per annum in cultivation capacity and be able to produce 1.2 million grams of concentrates.
We’re replicating profitable operations and well-established brands to build a multi-state presence
Most MPX Bioceutical Corporation’s operations are U.S.-based, but we have also applied for a license in Canada
Established brands like MPX, Health4Life, and Salus BioPharma meet the needs of adult recreational and medical cannabis users
MPX Bioceutical Corporation signed a definitive agreement to create a joint venture with Panaxia to develop proprietary, smokeless pharma-grade products using cannabis
Committed to consistent best-in-class quality
MPX Bioceutical Corporation Delivers
Profitable operations and a healthy balance sheet provides financial flexibility
From seed to sale, MPX Bioceutical Corporation controls quality ensuring consistent quality
Established brands capture both adult recreational and medical market share
Senior executives with strong track records focused on flawless execution
Canadian Bioceutical Teams Up with Israeli-based Panaxia
Canadian Bioceutical has teamed up with Panaxia to develop, market and sell pharma-grade cannabis products.